Qulipta (atogepant) is an oral calcitonin gene–related peptide (CGRP) receptor antagonist indicated for the preventive treatment of migraine in adults. It works by blocking the activity of CGRP, a protein involved in migraine attacks, helping to reduce the frequency and severity of migraine episodes. Qulipta is taken once daily and is not used to treat acute migraine attacks once they occur.
Qulipta
- Brands Qulipta
- Product Code: Qulipta
- Availability: In Stock
American Diabetes Association
Diabetes Disaster_Response Coalition storing insulin
FDA Approved Prescription
Available Options
Important Note: We can only ship a maximum 90-day supply of your prescription. If in doubt, please call before placing your order.
